Technology for Innovation in Radiation Oncology.

Radiation therapy is an effective, personalized cancer treatment that has benefited from technological advances associated with the growing ability to identify and target tumors with accuracy and precision. Given that these advances have played a central role in the success of radiation therapy as a major component of comprehensive cancer care, the American Society for Radiation Oncology (ASTRO), the American Association of Physicists in Medicine (AAPM), and the National Cancer Institute (NCI) sponsored a workshop entitled "Technology for Innovation in Radiation Oncology," which took place at the National Institutes of Health (NIH) in Bethesda, Maryland, on June 13 and 14, 2013. The purpose of this workshop was to discuss emerging technology for the field and to recognize areas for greater research investment. Expert clinicians and scientists discussed innovative technology in radiation oncology, in particular as to how these technologies are being developed and translated to clinical practice in the face of current and future challenges and opportunities. Technologies encompassed topics in functional imaging, treatment devices, nanotechnology, and information technology. The technical, quality, and safety performance of these technologies were also considered. A major theme of the workshop was the growing importance of innovation in the domain of process automation and oncology informatics. The technologically advanced nature of radiation therapy treatments predisposes radiation oncology research teams to take on informatics research initiatives. In addition, the discussion on technology development was balanced with a parallel conversation regarding the need for evidence of efficacy and effectiveness. The linkage between the need for evidence and the efforts in informatics research was clearly identified as synergistic.

Radiation hardness of the storage phosphor europium doped potassium chloride for radiation therapy dosimetry.

PURPOSE: An important property of a reusable dosimeter is its radiation hardness, that is, its ability to retain its dosimetric merits after irradiation. The radiation hardness of europium doped potassium chloride (KC1:Eu2+), a storage phosphor material recently proposed for radiation therapy dosimetry, is examined in this study. METHODS: Pellet-style KCl:Eu2+ dosimeters, 6 mm in diameter, and 1 mm thick, were fabricated in-house for this study. The pellets were exposed by a 6 MV photon beam or in a high dose rate 137Cs irradiator. Macroscopic properties, such as radiation sensitivity, dose response linearity, and signal stability, were studied with a laboratory photostimulated luminescence (PSL) readout system. Since phosphor performance is related to the state of the storage centers and the activator, Eu2+, in the host lattice, spectroscopic and temporal measurements were carried out in order to explore radiation-induced changes at the microscopic level. RESULTS: KCl:Eu2+ dosimeters retained approximately 90% of their initial signal strength after a 5000 Gy dose history. Dose response was initially supralinear over the dose range of 100-700 cGy but became linear after 60 Gy. Linearity did not change significantly in the 0-5000 Gy dose history spanned in this study. Annealing high dose history chips resulted in a return of supralinearity and a recovery of sensitivity. There were no significant changes in the PSL stimulation spectra, PSL emission spectra, photoluminescence spectra, or luminescence lifetime, indicating that the PSL signal process remains intact after irradiation but at a reduced efficiency due to reparable radiation-induced perturbations in the crystal lattice. CONCLUSIONS: Systematic studies of KCl:Eu2+ material are important for understanding how the material can be optimized for radiation therapy dosimetry purposes. The data presented here indicate that KCl:Eu2+ exhibits strong radiation hardness and lends support for further investigations of this novel material.

Comparison of small photon beams measured using radiochromic and silver-halide films in solid water phantoms.

In this study, we compared the dosimetric properties of four of the most commonly used films for megavoltage photon-beam dosimetry when irradiated under identical conditions by small multileaf-collimator (MLC) defined beamlets. Two silver-halide films (SHFs), Kodak XV2 and EDR2, and two radiochromic films (RCFs), Gafchromic HS and MD55-2, were irradiated by MLC-defined 1 x 1 cm2 beamlets from a Varian 2100 C/D linac equipped with a 120-leaf MLC. The beamlets were delivered with the accelerator gantry set laterally (90 degrees rotation) upon a solid-water compression film phantom at 100 cm source-to-surface distance which was positioned with the films parallel to the beam axis. Beamlets were delivered at central axis, 5.0 cm, and 10.5 cm off-axis for both leaf-end and leaf-side defined beamlets. The film dosimetry was performed using a quantitative optical density (OD) imaging system that was validated in a previous study. No significant differences between SHF and RCF measurements were observed in percentage depth doses, horizontal depth profiles, or two-dimension spatial isodose distributions in both the central axis and off-axis measurements. We found that regardless of the type of film used, RCF or SHF, a consistent data set for small beam dose modeling was generated. Previous validation studies based on the use of RCF and OD imaging system would indicate that all film produce an accurate result for small beam characterization.